Literature DB >> 12622098

The effect of Bacille Calmette-Guérin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS.

A Paolillo, M G Buzzi, E Giugni, U Sabatini, S Bastianello, C Pozzilli, M Salvetti, G Ristori.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12622098     DOI： 10.1007/s00415-003-0967-6

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  16 in total

Review 1.  Mycobacteria-induced suppression of autoimmunity in the central nervous system.

Authors:  JangEun Lee; Matyas Sandor; Erika Heninger; Zsuzsanna Fabry
Journal:  J Neuroimmune Pharmacol       Date:  2010-03-24       Impact factor: 4.147

2.  Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Goran Laćan; Hoa Dang; Blake Middleton; Marcus A Horwitz; Jide Tian; William P Melega; Daniel L Kaufman
Journal:  J Neurosci Res       Date:  2013-08-01       Impact factor: 4.164

3.  BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner.

Authors:  Valerie Acm Koeken; L Charlotte J de Bree; Vera P Mourits; Simone Jcfm Moorlag; Jona Walk; Branko Cirovic; Rob Jw Arts; Martin Jaeger; Helga Dijkstra; Heidi Lemmers; Leo Ab Joosten; Christine S Benn; Reinout van Crevel; Mihai G Netea
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

4.  Mycobacterium bovis bacille Calmette-Guérin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner.

Authors:  JangEun Lee; Emily K Reinke; Alla L Zozulya; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

5.  Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.

Authors:  Giovanni Ristori; Silvia Romano; Stefania Cannoni; Andrea Visconti; Emanuele Tinelli; Laura Mendozzi; Pietro Cecconi; Roberta Lanzillo; Mario Quarantelli; Carla Buttinelli; Claudio Gasperini; Marco Frontoni; Giulia Coarelli; Domenico Caputo; Vincenzo Bresciamorra; Nicola Vanacore; Carlo Pozzilli; Marco Salvetti
Journal:  Neurology       Date:  2013-12-04       Impact factor: 9.910

Review 6.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

7.  BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.

Authors:  Jing Yong; Goran Lacan; Hoa Dang; Terry Hsieh; Blake Middleton; Clive Wasserfall; Jide Tian; William P Melega; Daniel L Kaufman
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

Review 8.  Functional profiling of the gut microbiome in disease-associated inflammation.

Authors:  Daniela Börnigen; Xochitl C Morgan; Eric A Franzosa; Boyu Ren; Ramnik J Xavier; Wendy S Garrett; Curtis Huttenhower
Journal:  Genome Med       Date:  2013-07-31       Impact factor: 11.117

9.  BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation.

Authors:  Ryan C Keefe; Hiroyuki Takahashi; Lisa Tran; Kacie Nelson; Nathan Ng; Willem M Kühtreiber; Denise L Faustman
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

10.  Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.

Authors:  Denise L Faustman; Limei Wang; Yoshiaki Okubo; Douglas Burger; Liqin Ban; Guotong Man; Hui Zheng; David Schoenfeld; Richard Pompei; Joseph Avruch; David M Nathan
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.